CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Cardiac and Brain MRIdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04769310
NCT04769310N/ACompleted

Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study

Tulane University·interventional·Posted Feb 24, 2021·Updated Mar 5, 2026

In Brief

A clinical study evaluating Cardiac and Brain MRI for Atrial Fibrillation and 5 related conditions. Completed, enrolled 5 participants across 1 site.

Detailed Summary

Demonstrating the pathophysiological link between Left Atrial (LA) and Left Atrial Appendage (LAA) pathology and embolic strokes in non-Atrial Fibrillation (AF) individuals represents a major advance in stroke prevention strategies. Instead of relying on non-specific criteria for stroke risk assessment, the investigators propose to identify individuals with high-risk of embolic stroke using imaging criteria that reflect the underlying pathophysiology of embolic stroke of cardiac origin. the investigators can therefore lay the groundwork for future anticoagulation strategies for stroke prevention beyond AF.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 24, 2021
Enrollment StartApr 26, 2021
Primary CompletionJan 27, 2026
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 5.4 years ago

Interventions

Cardiac and Brain MRIdevice

A CMR to evaluate for LA and LAA high-risk features on either a 1.5 or 3 Tesla clinical MR scanner will be used. Gadolinium injection will be administered. Gadolinium is a contrast product that helps define areas of fibrosis in the LA. High-resolution brain MRI with no contrast will include the following sequences for most accurate assessment of embolic lesions: 3D T1 MPRAGE, 3D FLAIR, DWI, ADC, and SWI